Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) FCF Margin (2022 - 2025)

Gossamer Bio's FCF Margin history spans 4 years, with the latest figure at 350.13% for Q4 2025.

  • For Q4 2025, FCF Margin rose 2818.0% year-over-year to 350.13%; the TTM value through Dec 2025 reached 353.5%, down 35048.0%, while the annual FY2025 figure was 353.5%, 35048.0% down from the prior year.
  • FCF Margin reached 350.13% in Q4 2025 per GOSS's latest filing, down from 272.06% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 1547.16% in Q1 2022 to a low of 410.08% in Q2 2025.
  • Average FCF Margin over 4 years is 407.27%, with a median of 75.33% recorded in 2025.
  • The largest YoY upside for FCF Margin was 6585bps in 2025 against a maximum downside of -53147bps in 2025.
  • A 4-year view of FCF Margin shows it stood at 1391.12% in 2022, then rose by 9bps to 1513.97% in 2023, then plummeted by -125bps to 378.3% in 2024, then grew by 7bps to 350.13% in 2025.
  • Per Business Quant, the three most recent readings for GOSS's FCF Margin are 350.13% (Q4 2025), 272.06% (Q3 2025), and 410.08% (Q2 2025).